- Home
- BRX vs HALO Comparison
BRX vs HALO Comparison
Compare BRX & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRX
- HALO
- Stock Information
- Founded
- BRX 2011
- HALO 1998
- Country
- BRX United States
- HALO United States
- Employees
- BRX N/A
- HALO N/A
- Industry
- BRX Real Estate Investment Trusts
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BRX Real Estate
- HALO Health Care
- Exchange
- BRX Nasdaq
- HALO Nasdaq
- Market Cap
- BRX 8.0B
- HALO 7.4B
- IPO Year
- BRX 2013
- HALO N/A
- Fundamental
- Price
- BRX $24.79
- HALO $53.93
- Analyst Decision
- BRX Buy
- HALO Buy
- Analyst Count
- BRX 13
- HALO 9
- Target Price
- BRX $30.40
- HALO $63.56
- AVG Volume (30 Days)
- BRX 2.4M
- HALO 3.3M
- Earning Date
- BRX 04-28-2025
- HALO 05-06-2025
- Dividend Yield
- BRX 4.64%
- HALO N/A
- EPS Growth
- BRX 12.84
- HALO 55.40
- EPS
- BRX 1.05
- HALO 3.76
- Revenue
- BRX $1,302,325,000.00
- HALO $1,084,306,000.00
- Revenue This Year
- BRX $5.68
- HALO $25.77
- Revenue Next Year
- BRX $4.42
- HALO $18.01
- P/E Ratio
- BRX $23.61
- HALO $14.34
- Revenue Growth
- BRX 3.87
- HALO 25.64
- 52 Week Low
- BRX $21.32
- HALO $42.01
- 52 Week High
- BRX $30.67
- HALO $70.51
- Technical
- Relative Strength Index (RSI)
- BRX 42.89
- HALO 43.12
- Support Level
- BRX $25.39
- HALO $47.50
- Resistance Level
- BRX $26.59
- HALO $69.94
- Average True Range (ATR)
- BRX 0.52
- HALO 3.40
- MACD
- BRX -0.02
- HALO -0.89
- Stochastic Oscillator
- BRX 0.00
- HALO 27.94
About BRX Brixmor Property Group Inc.
Brixmor Property Group Inc is a real estate investment trust based in the United States. The company owns and operates a portfolio of grocery-anchored community and neighborhood shopping centers across the United States. It leases its rentable areas to retailers, restaurants, theatres, entertainment venues, and fitness centers, with the company's tenants consisting of large department stores, discount retailers, and grocery stores. The company is an internally managed REIT. The company operates in Florida, Texas, California, New York, Pennsylvania, Illinois, New Jersey, Georgia, North Carolina, Michigan, Ohio and other states.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.